A groundbreaking nasal spray using a form of ketamine to treat stubborn depression is set to become more accessible and affordable for thousands of Australians. The spray, known as Spravato, will be ...

The Pharmaceutical Benefits Scheme (PBS) has introduced a groundbreaking treatment for Australians suffering from treatment-resistant depression. Starting May 1, Spravato, a ketamine-based nasal spray ...

When Samuel Hockey's doctor suggested he try using a form of ketamine to treat his depression, he was curious."I sort of ...

The federal government has bankrolled the use of an artificial ketamine nasal spray to combat treatment-resistant depression, ...

A drug derived from ketamine will be added to the PBS, helping tens of thousands of Australians struggling with depression to ...

The nasal vaccine, tested on animals since 2021, may offer a new tool in fighting COVID-19 with a non-invasive, ...

A new nasal spray, that’s chemically similar to Ketamine, is being added to the Pharmaceutical Benefits Scheme, for adults ...

An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making it much cheaper for the ...

About Evoke Pharma, Inc. Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat ...

Experience nasal discomfort? Learn why your nose hurts when you press it or touch it and discover ways to alleviate nasal tenderness effectively.

A nasal spray that's having life-changing impacts on people living with depression is set to be listed on the PBS, slashing ...

Follow the latest news headlines from Australia's most trusted source. Read in-depth expert analysis and watch live coverage ...